1. Angiotensin I1 receptor binding was studied in specific regions of rat brain at different ages from birth to 14 weeks.
Introduction
Angiotensin I1 administered to the central nervous system has been shown to increase blood pressure (Severs & Daniels-Severs, 1973) , stimulate drinking (Severs & Daniels-Severs, 1973; Severs & Summy-Long, 1975; Epstein, 1978) and to release vasopressin (Mouw, Bonjour, Malvin & Vander, 1971) . It has been suggested that such responses could be mediated physiologically by endogenous brain angiotensin I1 (Ganten, 1978) . However, the presence of a functional renin-angiotensin system in brain has been disputed by several authors Correspondence: Dr John S. Horvath, Renal Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown N.S.W. 2050, Australia. (Reid, 1977 (Reid, , 1978 Horvath, Baxter, Furby & Tiller, 1977) . Moreover, there is considerable evidence that the major sites of action of angiotensin I1 in the brain are at areas where the bloodbrain barrier is imperfect (Elghozi, Fitzsimons, Myer & Nicolaidis, 1977) . These include the area postrema, which may be important for the control of blood pressure, and the subfornical organ, which is a major site for the dipsogenic responses to exogenous angiotensin 11. It has been postulated that circulating angiotensin I1 may act centrally through such sites to produce physiological responses (Elghozi et al., 1977 (Rapoport, 1976) it is possible that the brain is an important site of action of circulating angiotensin I1 shortly after birth. Extensive studies in vivo are required to test this hypothesis. However, the results of experiments in vitro presented here suggest that young rat brains contain particularly high numbers of angiotensin I1 receptors.
Methods
Male Oxford hooded rats were used for all experiments. Rats were killed by decapitation and brains were removed rapidly and dissected at 4OC (Glowinski & Iversen, 1966) . Membranes were prepared from individual brain parts by n ,nodification of the method of Bennet & Snyder (1976) . After preparation, brain membranes were resuspended in the incubation medium described by Bennet & Snyder (1976) with the addition of Trasylol (Bayer) (500 units/ml). Incubations were carried out for 60 min at 25OC with 0.1-1.0 mg of membrane protein (Lowry, Rosebrough, Farr & Randall, 1951) in a total volume of I ml. Incubation tubes contained i2sI-labelled angiotensin I1 (7.5 x mol/l) (New England Nuclear; 1000-1500 pCi/pg). Where unlabelled angiotensin I1 was added (to determine non-specific binding or for Scatchard plots) [Ile~~langiotensin I1 (Calbiochem) was used. Specific binding was defined as the difference between total binding of i2s-labelled angiotensin I1 (incubated in the absence of unlabelled angiotensin 11) and non-specific binding (determined by incubating with angiotensin 11, 1 pmolh). Membrane-bound angiotensin I1 was separated from free angiotensin I1 by centrifugation at 2000 g for 20 min. In experiments where rats were infused with saralasin ([Sari, Ala8]angiotensin 11; Eaton Laboratories), control and experimental rats were anaesthetized with intraperitoneal sodium pentobarbitone (100 rng/kg). Saralasin (15 pg rnin-' kg-l) was infused via a catheter in the jugular vein.
After 30 min, rats were killed and membranes were prepared from midbrains of infused and control rats.
Results
Angiotensin I1 receptors in all regions of rat brain increased during the first 2 weeks after birth, reaching binding values of up to 10 times those in adults (experiment 1, Table 1 ). Maximum receptor binding to midbrain and thalamus + hypothalamus membranes was found in tissue from 2 week old rats, whereas receptors in all other regions reached a peak at 1 week of age. Scatchard plots indicated that the differences observed in angiotensin I1 receptor binding, both between different regions of brain and between rats of different ages, were due to variations in receptor number rather than differences in affinity of binding. For example, the affinity constants obtained from Scatchard plots for midbrain membranes from 2 week old and 6 week old rats were 5.4 x lo9 1-mol and 4.9 x lo9 l/rnol, whereas the receptor numbers were 29.5 frnol/mg of protein and 10.5 fmol/mg of protein respectively.
In Table 1 (experiment 2), the effect of infusion of saralasin on midbrain angiotensin I1 receptors is shown. No difference was found in iZJI-labelled angiotensin I1 binding between saralasin-infused Results are expressed means 2 SD (n). Individual brain parts were used for membrane preparation, except for cerebrum and cerebellum, where tissue from five rats was pooled. In experiment 2, saralasin was infused into rats before midbrain membrane preparation, as described in the text. Student's t-test was used to determine significance (P).
N.S., Not significant. Age and angiotensin II receptors 113s and control rats for 6 week old rats. However, when 2 week old rats were used, a significant decrease was observed in the saralasin-infused rats.
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Discussion
Angiotensin I1 receptors in various regions of adult rat brain have been studied by other workers (Bennet et al., 1976; Sirrett et al., 1977) , who reported the highest receptor numbers in thalamus, hypothalamus and midbrain. The receptor numbers for brain regions of 6 weeks old rats given in Table  1 (experiment 1) show similar results to the previous reports. The present study, however, reveals that rapid changes occur in brain angiotensin I1 receptors during the first few weeks after birth, with receptor binding reaching peaks at 1 or 2 weeks of age ( Table 1 ) . The ratios of receptors in the different brain regions also change. In contrast to older rats, at 1 week of age the highest receptor binding was found in the brain stem. It is possible that such age-dependent variations in receptors from one brain region to another reflect changes in central nervous system responses to angiotensin I1 during early development. However, little is known about the ontogeny of the central effects of angiotensin I1 in the rat and an explanation for the above will have to await further studies.
The saralasin-infusion experiment ( Table 1) was carried out to test the ability of circulating angiotensin-like peptides to reach brain receptors. The angiotensin I1 analogue, saralasin, has been shown in this laboratory and by others (Sirrett et al., 1977) to bind strongly to brain angiotensin I1 receptors. The significant decrease in midbrain membrane receptors from saralasin-infused 2 week old rats, compared with controls (Table l), suggests that circulating saralasin (and probably angiotensin 11) is able to reach brain receptors in rats of this age. By contrast, there was no effect of saralasin infusion on angiotensin receptor binding to midbrain membranes from 6 week old rats. Angiotensin I1 is unable to cross the blood-brain barrier in adult animals (Ganten, Hutchinson & Shelling, 1975 ) and the results observed for 6 week old rats were therefore predictable. As whole midbrains were used in this experiment, the binding of saralasin to small sites without a blood-brain barrier would not be detected. The permeability of the blood-brain barrier to angiotensin in newborn animals has not been determined. However, there is evidence that the blood-brain barrier is underdeveloped at birth (Rapoport, 1976) . The saralasininfusion experiments in 2 week old rats suggest that areas which are within the blood-brain barrier in adults may be accessible to circulating angiotensin in newborn rats. This result, together with both the high brain angiotensin I1 receptor binding and high concentrations of circulating angiotensin I1 in young animals (Broughton Pipkin et al., 1974; Stalker et al., 1976) , suggests that central sites of action of angiotensin I1 may be particularly important in the newborn, and should be further investigated.
